Visual Field Testing
Customize your policy alerts
Sign up for Arizona Complete Health Policy CP.VP.63 alerts
Get alerted when Policy CP.VP.63 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity and coding guidance for visual field testing for members of health plans affiliated with Centene Corporation and Envolve Vision, Inc.; describes covered indications, noncovered indications, and associated CPT/ICD-10 codes.
No material clinical or coverage changes in this revision.
Coverage Criteria for Visual Field Testing
Diagnosis code listings
Diagnosis codes that support medical necessity for visual field testing include, but are not limited to, the following ICD-10-CM codes and code ranges (selected excerpts from the source list):
Diagnosis code listing (no explicit criteria)
Additional diagnosis codes (no explicit clinical criteria required beyond the presence of the listed diagnosis) from the source policy that support coverage for visual field testing include:
Coding: CPT and ICD-10 Codes
| G40.101 | Localization-related (focal) symptomatic epilepsy with simple partial seizures, not intractable, with status epilepticus |
| G40.109 | Localization-related (focal) symptomatic epilepsy with simple partial seizures, not intractable, without status epilepticus |
| G40.111 | Localization-related (focal) symptomatic epilepsy with simple partial seizures, intractable, with status epilepticus |
| G40.119 | Localization-related (focal) symptomatic epilepsy with simple partial seizures, intractable, without status epilepticus |
| G40.201 | Localization-related (focal) symptomatic epilepsy with complex partial seizures, not intractable, with status epilepticus |
| G40.209 | Localization-related (focal) symptomatic epilepsy with complex partial seizures, not intractable, without status epilepticus |
| G40.211 | Localization-related (focal) symptomatic epilepsy with complex partial seizures, intractable, with status epilepticus |
| G40.219 | Localization-related (focal) symptomatic epilepsy with complex partial seizures, intractable, without status epilepticus |
| G40.301 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable with status epilepticus |
| G40.309 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable without status epilepticus |
| H02.211 | Cicatricial lagophthalmos right upper eyelid |
| H02.212 | Cicatricial lagophthalmos right lower eyelid |
| H02.21A | Cicatricial lagophthalmos right eye, upper and lower eyelids |
| H02.21C | Cicatricial lagophthalmos, bilateral, upper and lower eyelids |
| H02.221 | Mechanical lagophthalmos right upper eyelid |
| H05.011 | Cellulitis of right orbit |
| H05.012 | Cellulitis of left orbit |
| H05.013 | Cellulitis of bilateral orbits |
| H05.021 | Osteomyelitis of right orbit |
| H05.031 | Periostitis of right orbit |
| H21.212 | Degeneration of chamber angle, left eye |
| H21.213 | Degeneration of chamber angle, bilateral |
| H21.221 | Degeneration of ciliary body, right eye |
| H21.222 | Degeneration of ciliary body, left eye |
| H21.223 | Degeneration of ciliary body, bilateral |
| H21.231 | Degeneration of iris (pigmentary), right eye |
| H21.232 | Degeneration of iris (pigmentary), left eye |
| H21.233 | Degeneration of iris (pigmentary), bilateral |
| H21.241 | Degeneration of pupillary margin, right eye |
| H21.242 | Degeneration of pupillary margin, left eye |
| H31.011 | Macula scars of posterior pole, right eye |
| H33.011 | Retinal detachment with single break, right eye |
| H33.012 | Retinal detachment with single break, left eye |
| H33.013 | Retinal detachment with single break, bilateral |
| H33.021 | Retinal detachment with multiple breaks, right eye |
| H33.022 | Retinal detachment with multiple breaks, left eye |
| H33.023 | Retinal detachment with multiple breaks, bilateral |
| H34.01 | Transient retinal artery occlusion, right eye |
| H34.02 | Transient retinal artery occlusion, left eye |
| H34.03 | Transient retinal artery occlusion, bilateral |
| H36.811 | Nonproliferative sickle-cell retinopathy, right eye |
| H40.011 | Open angle with borderline findings, low risk, right eye |
| H40.012 | Open angle with borderline findings, low risk, left eye |
| H40.013 | Open angle with borderline findings, low risk, bilateral |
| H40.1112 | Primary open-angle glaucoma, right eye, moderate stage |
| H40.013 | Primary open-angle glaucoma (alternate entry) |
| H40.021 | Open angle with borderline findings, high risk, right eye |
| H40.1113 | Primary open-angle glaucoma, right eye, severe stage |
| H40.1121 | Primary open-angle glaucoma, left eye, mild stage |
| H40.1122 | Primary open-angle glaucoma, left eye, moderate stage |
| H43.01 | Vitreous prolapse, right eye |
| H43.02 | Vitreous prolapse, left eye |
| H43.03 | Vitreous prolapse, bilateral |
| H43.11 | Vitreous hemorrhage, right eye |
| H43.12 | Vitreous hemorrhage, left eye |
| H43.13 | Vitreous hemorrhage, bilateral |
| H44.21 | Degenerative myopia, right eye |
| H44.22 | Degenerative myopia, left eye |
| H44.23 | Degenerative myopia, bilateral |
| H44.311 | Chalcosis, right eye |
| H46.01 | Optic papillitis, right eye |
| H46.02 | Optic papillitis, left eye |
| H47.011 | Ischemic optic neuropathy, right eye |
| H47.012 | Ischemic optic neuropathy, left eye |
| H47.013 | Ischemic optic neuropathy, bilateral |
| H47.21 | Primary optic atrophy, right eye |
| H47.22 | Hereditary optic atrophy |
| H47.231 | Glaucomatous optic atrophy, right eye |
| H47.232 | Glaucomatous optic atrophy, left eye |
| H47.611 | Cortical blindness, right side of brain |
| H54.0X33 | Blindness right eye category 3, blindness left eye category 3 |
| H54.0X34 | Blindness right eye category 3, blindness left eye category 4 |
| H54.0X35 | Blindness right eye category 3, blindness left eye category 5 |
| H54.8 | Legal blindness, as defined in USA |
| H53.15 | Visual distortions of shape and size |
| H53.16 | Psychophysical visual disturbances |
| S04.011A | Injury of optic nerve, right eye, initial encounter |
| S04.011D | Injury of optic nerve, right eye, subsequent encounter |
| S04.011S | Injury of optic nerve, right eye, sequela |
| S04.012A | Injury of optic nerve, left eye, initial encounter |
| S04.012D | Injury of optic nerve, left eye, subsequent encounter |
| S04.012S | Injury of optic nerve, left eye, sequela |
| S04.02XA | Injury of optic chiasm, initial encounter |
| S04.031A | Injury of optic tract and pathways, right eye, initial encounter |
| S04.032A | Injury of optic tract and pathways, left eye, initial encounter |
| S04.041A | Injury of visual cortex, right eye, initial encounter |
| I60.01 | Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation |
| I61.0 | Nontraumatic intracerebral hemorrhage in hemisphere, subcortical |
| I63.011 | Cerebral infarction due to thrombosis of right vertebral artery |
| I65.01 | Occlusion and stenosis of right vertebral artery |
| M31.5 | Giant cell arteritis with polymyalgia rheumatica |
| Q10.0 | Congenital ptosis |
| Q14.0 | Congenital malformation of vitreous humor |
Provider Actions, Prior Authorization, and Documentation
Use CPT 92081–92083; repeated testing beyond policy limits may be denied
Report visual field examinations with CPT codes 92081, 92082, and 92083; coverage is limited to the medical indications listed in the policy and repeated testing beyond policy frequency limits (for example, more than twice per year for controlled glaucoma) may be considered not medically necessary and denied.
No prior authorization specified in this segment
This document segment does not state any prior authorization requirement for visual field testing; it provides diagnosis code listings that may support medical necessity.
Prior authorization not specified
No prior authorization requirements are specified in the provided text for reporting visual field examinations.
Provide an appropriate ICD-10 diagnosis from the listed codes
This excerpt contains ICD-10 diagnosis codes that are used to support medical necessity for visual field testing; check other policy sections for any explicit prior authorization rules.
No prior authorization rules in this segment
No prior authorization rules are stated in this portion of the policy; the content provided is diagnosis code listings rather than authorization criteria.
Prior authorization not specified here
No prior authorization requirements are stated in the chunks covered by this segment.
Verify program‑specific coverage rules (Medicaid/Medicare)
For Medicaid members, state Medicaid coverage provisions take precedence over this clinical policy; for Medicare members, review applicable Medicare NCDs and LCDs prior to applying the policy criteria.
- Verify state Medicaid manual provisions for Medicaid members.
- Check relevant Medicare NCDs/LCDs and Coverage Articles for Medicare members.
No step therapy requirements in this segment
No step therapy requirements are included in this code‑list segment of the policy.
Report CPT 92081–92083 with interpretation/report and supporting documentation
Report visual field examinations with CPT codes 92081, 92082, or 92083 and include interpretation and a report; ensure clinical documentation supports the chosen ICD-10 diagnosis used to substantiate medical necessity.
- Include interpretation and a formal report when submitting CPT 92081–92083.
- Document clinical indication and the specific ICD-10 diagnosis code from the policy to substantiate medical necessity.
ICD-10 codes provided to support claims; no template specified
The code lists provide ICD-10 diagnosis codes that may be used to support claims, but this segment does not include a required documentation template.
Use provided ICD-10 codes to support medical necessity
The ICD-10 diagnosis codes and descriptions in this segment may be used to support medical necessity for visual field testing when billed.
Include a specific ICD-10 diagnosis from the policy on the claim
Include the specific ICD-10 diagnosis code from the provided list (for example H21.*, H30.*, H33.*, H34.*, H35.*, H40.*) on the claim to substantiate medical necessity for visual field testing.
- Select the most specific ICD-10 code from the policy's lists to match the clinical indication.
- Ensure the claim diagnosis matches documented clinical findings in the patient record.
ICD-10 code listings available to support documentation
This segment provides ICD-10 diagnosis codes and descriptions that may be used to support documentation for visual field testing claims.
Use ICD-10 descriptions to align billing with clinical indication
ICD-10 codes with descriptions in this segment may be used to support medical necessity when billing for visual field testing; ensure the chosen code aligns with the documented clinical indication.
Follow Health Plan administrative policies and document clinical indications
Providers must follow Health Plan‑level administrative policies and procedures and document clinical indications consistent with this policy and the member's coverage documents.
- Maintain clinical records documenting the indication for testing.
- Follow Health Plan administrative submission rules when filing claims.
Denial risk for repeated testing / >2 tests/year for controlled glaucoma
Repeated testing for a stable, diagnosed condition or testing that exceeds twice per year for controlled glaucoma is considered not medically necessary and may result in claim denial.
- Avoid routine repeat visual field tests for stable conditions without documented clinical change.
- Limit routine testing for controlled glaucoma to no more than twice per year unless clinical justification is documented.
Diagnosis codes listed; no authorization language here
This chunk contains diagnosis codes rather than explicit authorization or denial language; refer to other policy sections for authorization details.
Code listings only — no authorization triggers shown
No explicit authorization or denial triggers are present in these code listing chunks; they list ICD-10 diagnosis codes and descriptions only.
Claims risk if an appropriate ICD-10 diagnosis is not present
Absence of an appropriate ICD-10 diagnosis from the listed ophthalmic codes may fail to support medical necessity and could lead to claim denial.
- Ensure the claim includes an ICD-10 code from the policy list that matches the documented clinical indication.
No authorization-specific denial triggers in code list
This portion contains diagnosis code listings only and does not present authorization-specific denial triggers.
Diagnosis code list only — no explicit authorization language
This part of the policy contains ICD-10 diagnosis code lists without explicit authorization or denial language.
Coverage decisions subject to plan terms; out-of-scope services may be denied
Coverage decisions are subject to all terms, conditions, exclusions and limitations of the member's coverage documents; services outside those terms may be denied.
- Confirm member eligibility and benefit limits before performing tests.
- Claims for services that fall outside coverage documents may be denied.
Background
Visual field testing (perimetry) is a diagnostic modality that maps central and peripheral vision to identify areas of decreased or lost vision and to help localize pathology along the visual pathway. Standard automated white-on-white perimetry (e.g., Humphrey) is commonly used for quantitative assessment, while alternative modalities such as Frequency-Doubling Technology (FDT) / Matrix perimetry can be useful for screening. Findings from visual field tests assist in diagnosing and monitoring glaucoma, retinal and optic nerve disorders, neurologic lesions, and other causes of visual field loss.
Definitions and Test Modalities
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.